PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IDEAYA Biosciences, Inc. (IDYA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45166A1025

CUSIP

45166A102

Sector

Healthcare

IPO Date

May 23, 2019

Highlights

Market Cap

$2.28B

EPS (TTM)

-$2.33

Total Revenue (TTM)

$3.92M

Gross Profit (TTM)

$720.00K

EBITDA (TTM)

-$223.50M

Year Range

$24.72 - $47.74

Target Price

$55.79

Short %

11.52%

Short Ratio

8.86

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
IDYA vs. ELEV IDYA vs. IOVA IDYA vs. RXST IDYA vs. IR IDYA vs. RXRX IDYA vs. SPY
Popular comparisons:
IDYA vs. ELEV IDYA vs. IOVA IDYA vs. RXST IDYA vs. IR IDYA vs. RXRX IDYA vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in IDEAYA Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-31.65%
7.20%
IDYA (IDEAYA Biosciences, Inc.)
Benchmark (^GSPC)

Returns By Period

IDEAYA Biosciences, Inc. had a return of -30.33% year-to-date (YTD) and -26.11% in the last 12 months.


IDYA

YTD

-30.33%

1M

-4.14%

6M

-31.65%

1Y

-26.11%

5Y*

22.28%

10Y*

N/A

^GSPC (Benchmark)

YTD

23.00%

1M

-0.84%

6M

7.20%

1Y

24.88%

5Y*

12.77%

10Y*

10.96%

Monthly Returns

The table below presents the monthly returns of IDYA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202422.34%2.69%-1.83%-7.36%-10.09%-3.94%22.61%-8.25%-19.80%-11.14%-2.81%-30.33%
2023-6.27%3.64%-22.21%32.99%25.08%2.89%-4.85%31.31%-8.11%0.70%15.75%13.13%95.82%
2022-29.91%-20.34%-15.23%-14.30%16.27%23.77%8.12%-34.12%51.78%13.20%5.86%1.62%-23.14%
202125.57%8.48%23.23%-12.55%-1.95%4.17%16.72%-4.08%8.47%-15.89%2.61%7.45%68.86%
202014.00%-18.13%-41.14%34.71%76.40%45.15%-11.26%-4.04%3.80%-3.11%14.54%0.43%86.67%
20196.08%-16.09%-28.61%-4.36%32.35%-37.00%34.92%-1.96%-32.98%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IDYA is 18, meaning it’s performing worse than 82% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of IDYA is 1818
Overall Rank
The Sharpe Ratio Rank of IDYA is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of IDYA is 1919
Sortino Ratio Rank
The Omega Ratio Rank of IDYA is 2121
Omega Ratio Rank
The Calmar Ratio Rank of IDYA is 1414
Calmar Ratio Rank
The Martin Ratio Rank of IDYA is 1818
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for IDYA, currently valued at -0.59, compared to the broader market-4.00-2.000.002.00-0.591.83
The chart of Sortino ratio for IDYA, currently valued at -0.64, compared to the broader market-4.00-2.000.002.004.00-0.642.46
The chart of Omega ratio for IDYA, currently valued at 0.93, compared to the broader market0.501.001.502.000.931.34
The chart of Calmar ratio for IDYA, currently valued at -0.59, compared to the broader market0.002.004.006.00-0.592.72
The chart of Martin ratio for IDYA, currently valued at -1.21, compared to the broader market0.0010.0020.00-1.2111.89
IDYA
^GSPC

The current IDEAYA Biosciences, Inc. Sharpe ratio is -0.59. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of IDEAYA Biosciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.59
1.83
IDYA (IDEAYA Biosciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


IDEAYA Biosciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-47.40%
-3.66%
IDYA (IDEAYA Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the IDEAYA Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IDEAYA Biosciences, Inc. was 74.64%, occurring on Mar 17, 2020. Recovery took 63 trading sessions.

The current IDEAYA Biosciences, Inc. drawdown is 47.40%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-74.64%May 30, 2019202Mar 17, 202063Jun 16, 2020265
-69.42%Sep 23, 2021158May 9, 2022323Aug 22, 2023481
-47.4%Feb 20, 2024212Dec 19, 2024
-39.58%Jun 18, 202046Aug 21, 2020102Jan 19, 2021148
-30.49%Apr 6, 202166Jul 8, 202140Sep 2, 2021106

Volatility

Volatility Chart

The current IDEAYA Biosciences, Inc. volatility is 15.10%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
15.10%
3.62%
IDYA (IDEAYA Biosciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of IDEAYA Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for IDEAYA Biosciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab